The impact of preoperative waiting time in Stage II-III gastric or gastroesophageal junction cancer: A population-based cohort study.
Chih-Chieh YenYi-Hsin YangHsiu-Ying KuHuang-Ming HuSu-Shun LoHung-Chi ChangYee ChaoJen-Shi ChenHsiu-Po WangTsang-En WangLi-Yuan BaiMing-Shiang WuChia-Jui YenLi-Tzong ChenYan-Shen ShanPublished in: Cancer medicine (2023)
The population-based study suggests that a PreWT of 49-118 days does not independently correlate with a poor prognosis in Stage II-III gastric cancer. The study provides rationale for a window period for preoperative therapies and patient optimization.